about
Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patientsNew approaches for precise response evaluation in hepatocellular carcinomaPositron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected ReviewPrognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysisNeoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomographyValue of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreasAnalysis and interpretation of dynamic FDG PET oncological studies using data reduction techniques.Positron emission tomography (PET) in the evaluation of patients with cancer.Benign Schwannoma Mimicking Metastatic Lesion on F-18 FDG PET/CT in Differentiated Thyroid Cancer(18)F-FLT PET/CT imaging in a Wister rabbit inflammation model.Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumoursCharacterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.A new way to look at inflammatory bowel disease.Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomographyApplication of F-18-sodium fluoride (NaF) dynamic PET-CT (dPET-CT) for defect healing: a comparison of biomaterials in an experimental osteoporotic rat model.Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.Positron Emission Tomography (PET) in OncologyCombined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.The next generation of positron emission tomography radiopharmaceuticals in oncology.Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.Breast cancer metastasis and the lymphatic systemCarbon-11-methionine and PET in evaluation of treatment response of breast cancerPET imaging of primary mediastinal tumoursReview of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano CarriersComparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma.Analytical study of the effect of the system geometry on photon sensitivity and depth of interaction of positron emission mammography.Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancerUse of positron emission tomography in evaluation of brachial plexopathy in breast cancer patientsFDG-PET. A possible prognostic factor in head and neck cancer.Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma.Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT.Role of (18)F-fluorodeoxyglucose Positron Emission Tomography scan in differentiating enhancing brain tumors.[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.Overview of early response assessment in lymphoma with FDG-PET.Induction and concurrent taxanes enhance both the pulmonary metabolic radiation response and the radiation pneumonitis response in patients with esophagus cancerFDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor modelInhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells
P2860
Q26822749-691A01C9-D789-47EF-BF64-9544F7E74BE5Q26866367-71E1FFBB-41BE-43D6-9E4F-2ECC88B0AD8FQ27009240-09F9C4B2-718E-4949-BD36-A5C6A4A6C108Q28077401-A76820A6-2484-457E-A472-3E25601F17F8Q28354052-EFB2B9C0-4C21-4496-AF04-0BACF367AB01Q28362865-8E79E2F5-C419-45AF-AAE5-6EDE9D4F85E2Q31132172-FB809C3F-485E-4AE2-ADC8-6B86CF37B021Q33645007-CD0A0986-E54E-4E8D-AAED-BC4FED6E2112Q33700971-E60AF81C-043F-4D3E-8AE8-6C389E3B718CQ33769525-07E3081A-868B-4C12-A7CA-0C93D9AA0B15Q33956190-6E30DDC2-7C9E-4893-859C-4BDF22222850Q33995787-10DD7C7E-9113-46C3-BC7D-B52F380813C5Q34032771-F346F1DF-B13F-418C-8B23-4374542E4F75Q34090293-F6E1156B-79F1-47D6-B59E-18983FA50D7CQ34408350-A77BE43D-F057-4BEC-B2D6-B9265C00434DQ34409271-806F1AF7-7660-4379-9CBD-64FB5B40A3FEQ34771664-F6E3AD9A-4E9F-4CA9-AC03-9A502D6E6442Q34774840-8C537EB1-FC3F-44A0-8992-6E20B10D7363Q35402102-57B49B48-8461-4AB1-A366-ADA67528B6D7Q35455732-961C4B41-3FC2-480B-9223-AF8807A0F873Q35525690-D72A49F3-E023-42DB-A479-2A5724979A27Q35568722-49329475-505A-4651-BB86-FCEEEDDA8B97Q35670667-362E832A-6739-4652-8832-B53DDFC140A1Q35942984-E317D816-A21E-42FD-AD45-49EBE7E0694BQ35976441-5A861B6B-4BC8-42BD-882E-3329DA8C7BF4Q36134346-67C95D34-DF74-41E0-A4EA-070E3389152FQ36176439-25F6D91F-9E5A-4E11-AD67-F5678FAB1E66Q36205152-E0010841-00BA-435C-85B8-128079C67578Q36282621-5BE87EA6-82EA-4B4F-A9CC-986C2A80000DQ36602216-9EB14379-959F-432F-B7C8-9DA285E5BFEAQ36618126-BCE12D87-D9CA-4E06-A7D1-014B4D09FBBAQ36644134-CA1FA510-F7C7-42F5-B4A4-0C5AECDDEE95Q36694607-28B6438F-3B33-4F8A-A1E7-6E051D5FE0ABQ36695918-E3B34A2E-529F-424C-B9D5-C9FB7B5D8F43Q36732567-9C95DC2A-3781-4A7A-9D73-609430EC4B1AQ36766549-604D4DB9-2719-45B2-8955-BEE69720440CQ36927213-91F4A3D4-2D21-40A7-9B53-D515665CFFC6Q36968133-5BA985E1-EA81-4C09-A2CA-9BF2E30079FEQ37063643-5B993ECF-6652-4D43-8D00-88CA713F72BCQ37071513-148B717F-03D5-47B3-A92F-87CE0F2DBA65
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The applications of PET in clinical oncology.
@en
The applications of PET in clinical oncology.
@nl
type
label
The applications of PET in clinical oncology.
@en
The applications of PET in clinical oncology.
@nl
prefLabel
The applications of PET in clinical oncology.
@en
The applications of PET in clinical oncology.
@nl
P1476
The applications of PET in clinical oncology.
@en
P2093
P304
623-48; discussion 649-50
P407
P577
1991-04-01T00:00:00Z